The preservation of HIV-1-specific CD8+ T cell function when ART is initiated before seroconversion is in agreement with the cases in which ART was initiated at the time of primary infection and long-term immunological control was achieved after treatment interruption [17, 18]. Here, CD8A is linked to infection.